Works matching IS 21623619 AND DT 2024 AND VI 13 AND IP 1
Results: 114
Disrupting Notch signaling related HES1 in myeloid cells reinvigorates antitumor T cell responses.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00588-2
- By:
- Publication type:
- Article
AOH1996 targets mitochondrial dynamics and metabolism in leukemic stem cells via mitochondrial PCNA inhibition.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Chiglitazar diminishes the warburg effect through PPARγ/mTOR/PKM2 and increases the sensitivity of imatinib in chronic myeloid leukemia.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00589-1
- By:
- Publication type:
- Article
Malignant pleural effusion facilitates the establishment and maintenance of tumor organoid biobank with multiple patient-derived lung tumor cell sources.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Radiation-induced exosomal miR-21 enhances tumor proliferation and invasiveness in breast cancer: implications for poor prognosis in radiotherapy patients.
- Published in:
- 2024
- By:
- Publication type:
- Letter
The development and application of chimeric antigen receptor natural killer (CAR-NK) cells for cancer therapy: current state, challenges and emerging therapeutic advances.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00583-7
- By:
- Publication type:
- Article
Targeting SPP1-orchestrated neutrophil extracellular traps-dominant pre-metastatic niche reduced HCC lung metastasis.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00571-x
- By:
- Publication type:
- Article
CUL4A-DDB1-circRFWD2 E3 ligase complex mediates the ubiquitination of p27 to promote multiple myeloma proliferation.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Identification of a novel subtype of SPP1 + macrophages expressing SIRPα: implications for tumor immune evasion and treatment response prediction.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00587-3
- By:
- Publication type:
- Article
High-throughput screening for optimizing adoptive T cell therapies.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00580-w
- By:
- Publication type:
- Article
Natural killer cell biology and therapy in multiple myeloma: challenges and opportunities.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00578-4
- By:
- Publication type:
- Article
Chimeric antigen receptor-T cell therapy for T cell-derived hematological malignancies.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00584-6
- By:
- Publication type:
- Article
Prospective pharmacotyping of urothelial carcinoma organoids for drug sensitivity prediction – feasibility and real world experience.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Targeting SPP1-orchestrated neutrophil extracellular traps-dominant pre-metastatic niche reduced HCC lung metastasis.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00571-x
- By:
- Publication type:
- Article
New insights into CAR T-cell hematological toxicities: manifestations, mechanisms, and effective management strategies.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00573-9
- By:
- Publication type:
- Article
Nuclear porcupine mediates XRCC6/Ku70 S-palmitoylation in the DNA damage response.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00572-w
- By:
- Publication type:
- Article
Crosstalk between O-GlcNAcylation and ubiquitination: a novel strategy for overcoming cancer therapeutic resistance.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00569-5
- By:
- Publication type:
- Article
Vertical targeting of the PI3K/AKT pathway at multiple points is synergistic and effective for non-Hodgkin lymphoma.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00576-6
- By:
- Publication type:
- Article
Spatial immunogenomic patterns associated with lymph node metastasis in lung adenocarcinoma.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00574-8
- By:
- Publication type:
- Article
Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00577-5
- By:
- Publication type:
- Article
Optimizing CD8<sup>+</sup> T cell-based immunotherapy via metabolic interventions: a comprehensive review of intrinsic and extrinsic modulators.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00575-7
- By:
- Publication type:
- Article
CRISPR/Cas9 technology for advancements in cancer immunotherapy: from uncovering regulatory mechanisms to therapeutic applications.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00570-y
- By:
- Publication type:
- Article
Natural killer cell-based cancer immunotherapy: from basics to clinical trials.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00561-z
- By:
- Publication type:
- Article
CD19/CD22 CAR-T-cell cocktail therapy following autologous transplantation is an optimizing strategy for treating relapsed/refractory central nervous system lymphoma.
- Published in:
- 2024
- By:
- Publication type:
- Letter
AXL as immune regulator and therapeutic target in Acute Myeloid Leukemia: from current progress to novel strategies.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00566-8
- By:
- Publication type:
- Article
Preclinical investigations and a first-in-human phase 1a trial of JS007, a novel anti-CTLA-4 antibody, in patients with advanced solid tumors.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00567-7
- By:
- Publication type:
- Article
Combined inhibition of MET and VEGF enhances therapeutic efficacy of EGFR TKIs in EGFR-mutant non-small cell lung cancer with concomitant aberrant MET activation.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00565-9
- By:
- Publication type:
- Article
Therapeutic targets of armored chimeric antigen receptor T cells navigating the tumor microenvironment.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00564-w
- By:
- Publication type:
- Article
Comprehensive antitumor immune response boosted by dual inhibition of SUMOylation and MEK in MYC-expressing KRAS-mutant cancers.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Targeting hepcidin in colorectal cancer triggers a TNF-dependent-gasdermin E-driven immunogenic cell death response.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Correction: Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Identifying ADGRG1 as a specific marker for tumor-reactive T cells in acute myeloid leukemia.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00560-0
- By:
- Publication type:
- Article
Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00552-0
- By:
- Publication type:
- Article
Polyunsaturated fatty acids promote M2-like TAM deposition via dampening RhoA-YAP1 signaling in the ovarian cancer microenvironment.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00558-8
- By:
- Publication type:
- Article
Genetic factors, risk prediction and AI application of thrombotic diseases.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00555-x
- By:
- Publication type:
- Article
Application patterns and outcomes of hematopoietic stem cell transplantation in peripheral T-cell lymphoma patients: a multicenter real-world study in China.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Current and future therapies for follicular lymphoma.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00551-1
- By:
- Publication type:
- Article
Epigenetic alterations of TP53INP1 by EHMT2 regulate the cell cycle in gastric cancer.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00553-z
- By:
- Publication type:
- Article
Enhanced depletion of MLL-fusion proteins in acute leukemia: potential for improved therapeutic outcomes.
- Published in:
- 2024
- By:
- Publication type:
- Letter
M2-like tumor-associated macrophage-secreted CCL2 facilitates gallbladder cancer stemness and metastasis.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00550-2
- By:
- Publication type:
- Article
Measurable therapeutic antibody in serum as potential predictive factor of response to anti-CD38 therapy in non-IgG-k myeloma patients.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Hematopoietic stem/progenitor cell transplantation recovers immune defects and prevents lymphomas in Atm-deficient mice.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00543-1
- By:
- Publication type:
- Article
The next frontier in immunotherapy: potential and challenges of CAR-macrophages.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00549-9
- By:
- Publication type:
- Article
Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilities.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00548-w
- By:
- Publication type:
- Article
Overexpression of ESYT3 improves radioimmune responses through activating cGAS-STING pathway in lung adenocarcinoma.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00546-y
- By:
- Publication type:
- Article
Cell membrane patches transfer CAR molecules from a cellular depot to conventional T cells for constructing innovative fused-CAR-T cells without necessitating genetic modification.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Role of CDK4 as prognostic biomarker in Soft Tissue Sarcoma and synergistic effect of its inhibition in dedifferentiated liposarcoma sequential treatment.
- Published in:
- 2024
- By:
- Publication type:
- Letter